Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles.

Operti MC, Dölen Y, Keulen J, van Dinther EAW, Figdor CG, Tagit O.

Pharmaceutics. 2019 Nov 8;11(11). pii: E590. doi: 10.3390/pharmaceutics11110590.

2.

A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles.

Operti MC, Fecher D, van Dinther EAW, Grimm S, Jaber R, Figdor CG, Tagit O.

Int J Pharm. 2018 Oct 25;550(1-2):140-148. doi: 10.1016/j.ijpharm.2018.08.044. Epub 2018 Aug 23.

PMID:
30144511
3.

Pre-Microporation Improves Outcome of Pancreatic Islet Labelling for Optical and 19F MR Imaging.

Herynek V, Gálisová A, Srinivas M, van Dinther EAW, Kosinová L, Ruzicka J, Jirátová M, Kriz J, Jirák D.

Biol Proced Online. 2017 Jun 28;19:6. doi: 10.1186/s12575-017-0055-4. eCollection 2017.

4.

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.

Dölen Y, Kreutz M, Gileadi U, Tel J, Vasaturo A, van Dinther EA, van Hout-Kuijer MA, Cerundolo V, Figdor CG.

Oncoimmunology. 2015 Aug 12;5(1):e1068493. eCollection 2016.

5.

Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread.

Büll C, Boltje TJ, van Dinther EA, Peters T, de Graaf AM, Leusen JH, Kreutz M, Figdor CG, den Brok MH, Adema GJ.

ACS Nano. 2015 Jan 27;9(1):733-45. doi: 10.1021/nn5061964. Epub 2015 Jan 14.

PMID:
25575241

Supplemental Content

Loading ...
Support Center